 GlyCanDrug MSCA-DN

GlyCanDrug is a European Training Network funded in the framework of HORIZON Marie Skłodowska-Curie Doctoral Networks (DN). It is a glycoscience-oriented DN that aims, for the first time, to take a step ahead in the design of precision therapeutics targeting key glycan motifs implicated in cancer.
More info on https://www.glycandrug.eu/